Susceptibility of human immunodeficiency virus type 1 replication in vitro to acyclic adenosine analogs and synergy of the analogs with 3'-azido-3'-deoxythymidine. — M S Smith (2020) | RDL Network
Susceptibility of human immunodeficiency virus type 1 replication in vitro to acyclic adenosine analogs and synergy of the analogs with 3'-azido-3'-deoxythymidine.
Certains dérivés acycliques de l'adénosine inhibent la réplication in vitro du virus HIV type 1 et leur combinaison avec la zidovudine produit un effet synergique.
Wim Pluymers, Godwin C. G. Pais, Bénédicte Van Maele, Christophe Pannecouque, Valery Fikkert, Terrence R. Burke, De Clercq Erik, Myriam Witvrouw, Nouri Neamati, Zeger Debyser
Jean‐Claude Schmit, Jacqueline Cogniaux, P. Hermans, Christophe VAN VAECK, S Sprecher, Barbara Van Remoortel, Myriam Witvrouw, Jan Balzarini, Jan Desmyter, De Clercq Erik, Anne‐Mieke Vandamme
Discussion(0)
No comments yet. Be the first to comment.